Your browser doesn't support javascript.
loading
Survival of a surgical series of lung cancer patients with synchronous multiple ground-glass opacities, and the management of their residual lesions.
Shimada, Yoshihisa; Saji, Hisashi; Otani, Keishi; Maehara, Sachio; Maeda, Junichi; Yoshida, Koichi; Kato, Yasufumi; Hagiwara, Masaru; Kakihana, Masatoshi; Kajiwara, Naohiro; Ohira, Tatsuo; Akata, Soichi; Ikeda, Norihiko.
Afiliação
  • Shimada Y; First Department of Surgery, Tokyo Medical University Hospital, Tokyo, Japan. Electronic address: zenkyu@za3.so-net.ne.jp.
  • Saji H; Department of Chest Surgery, St. Marianna University School of Medicine, Yokohama, Japan.
  • Otani K; First Department of Surgery, Tokyo Medical University Hospital, Tokyo, Japan.
  • Maehara S; First Department of Surgery, Tokyo Medical University Hospital, Tokyo, Japan.
  • Maeda J; First Department of Surgery, Tokyo Medical University Hospital, Tokyo, Japan.
  • Yoshida K; First Department of Surgery, Tokyo Medical University Hospital, Tokyo, Japan.
  • Kato Y; First Department of Surgery, Tokyo Medical University Hospital, Tokyo, Japan.
  • Hagiwara M; First Department of Surgery, Tokyo Medical University Hospital, Tokyo, Japan.
  • Kakihana M; First Department of Surgery, Tokyo Medical University Hospital, Tokyo, Japan.
  • Kajiwara N; First Department of Surgery, Tokyo Medical University Hospital, Tokyo, Japan.
  • Ohira T; First Department of Surgery, Tokyo Medical University Hospital, Tokyo, Japan.
  • Akata S; Department of Radiology, Tokyo Medical University Hospital, Tokyo, Japan.
  • Ikeda N; First Department of Surgery, Tokyo Medical University Hospital, Tokyo, Japan.
Lung Cancer ; 88(2): 174-80, 2015 May.
Article em En | MEDLINE | ID: mdl-25758554
OBJECTIVES: We reviewed the medical record of a series of patients with synchronous multiple lung cancers (SMLC), in an attempt to identify the optimal treatment strategy for multiple ground-glass opacities (GGOs). MATERIALS AND METHODS: From 2004 to 2010, 1223 patients underwent complete resection of non-small cell lung cancer. Among these, there were 67 patients (5.5%) with SMLC with at least 1 of the nodules showing GGO appearance. SMLC was divided into the main cancer (MC) which was a main target based on its tumor size or radiological invasiveness and sub-nodules. According to consolidation/tumor ratio (CTR) on thin-section computed tomography, 67 cases were classified into GG-group (MC showing GGO-dominant lesion; CTR≤0.5) and GS-group (MC showing solid-dominant lesion; CTR>0.5). RESULTS: There were 24 patients in the GG-group (36%) and 43 patients in the GS-group (64%). Surgical resections included 11 sublobar resections (SLs), 32 lobectomies, 19 lobectomy+SLs, and 4 bilobectomies. There were 39 patients with a total of 118 unresected GGOs after the initial surgery. Among them, the frequency of growth was 8% on a per-nodule basis with the median tumor doubling time of 1373 days, and new GGOs emerged in 15 patients (23%). Multivariate analysis demonstrated that larger size of MC and the GS-group was associated with poor prognosis, whereas growth of the residual GGOs, the development of new GGOs, or whether or not all GGOs were treated did not affect survival. The 5-year OS proportions were 95.8% for the GG-group and 68.0% for the GS-group (p=0.009), and 92.4% for a MC of ≤25 mm and 53.6% for a MC of >25 mm (p=0.008). CONCLUSION: Survival of patients with multifocal GGOs is strongly affected by radiological findings of the MC. Strict surgical control for MC could be most important.
Assuntos
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Pulmão / Neoplasias Pulmonares Idioma: En Ano de publicação: 2015 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Pulmão / Neoplasias Pulmonares Idioma: En Ano de publicação: 2015 Tipo de documento: Article